These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38161493)

  • 21. Distinctive clinical and genetic features of lean vs overweight fatty liver disease using the UK Biobank.
    Chahal D; Sharma D; Keshavarzi S; Arisar FAQ; Patel K; Xu W; Bhat M
    Hepatol Int; 2022 Apr; 16(2):325-336. PubMed ID: 35178663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence, characteristics and mortality outcomes of obese, nonobese and lean NAFLD in the United States, 1999-2016.
    Zou B; Yeo YH; Nguyen VH; Cheung R; Ingelsson E; Nguyen MH
    J Intern Med; 2020 Jul; 288(1):139-151. PubMed ID: 32319718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Features of Non-Alcoholic Fatty Liver Disease in the Non-Lean Population.
    Li MR; Li JZ; Li JY; Wang CC; Yuan RK; Ye LH; Liu YY; Liang XJ; Zhang HC; Liu ZQ; Zeng DY; Zhang XD; Wang DH; Li JQ; Li TY; Yang L; Cao Y; Pan Y; Lin XG; Pan CQ; Dai EH; Dong ZY
    Obes Facts; 2023; 16(5):427-434. PubMed ID: 37231905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different predictors of steatosis and fibrosis severity among lean, overweight and obese patients with nonalcoholic fatty liver disease.
    Shao C; Ye J; Li F; Feng S; Wang W; Zhong B
    Dig Liver Dis; 2019 Oct; 51(10):1392-1399. PubMed ID: 30928418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-obese or lean non-alcoholic fatty liver disease was associated with increased risk of cancer in patients with type 2 diabetes mellitus.
    Chen N; Zhou J; Wang K; Li X; Li Z
    BMJ Open Diabetes Res Care; 2023 Feb; 11(1):. PubMed ID: 36792168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology of lean/non-obese nonalcoholic fatty liver disease in China: A systematic review and meta-analysis.
    Zhang J; Huang X; Dong L; Yang Y; Kong D
    Saudi Med J; 2023 Sep; 44(9):848-863. PubMed ID: 37717964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lean non-alcoholic fatty liver disease and the risk of all-cause mortality: An updated meta-analysis.
    Wongtrakul W; Charatcharoenwitthaya N; Charatcharoenwitthaya P
    Ann Hepatol; 2024; 29(3):101288. PubMed ID: 38278181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: A long-term follow-up study.
    Hagström H; Nasr P; Ekstedt M; Hammar U; Stål P; Hultcrantz R; Kechagias S
    Hepatol Commun; 2018 Jan; 2(1):48-57. PubMed ID: 29404512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonalcoholic Fatty Liver Disease in Lean/Nonobese and Obese Individuals: A Comprehensive Review on Prevalence, Pathogenesis, Clinical Outcomes, and Treatment.
    Patel AH; Peddu D; Amin S; Elsaid MI; Minacapelli CD; Chandler TM; Catalano C; Rustgi VK
    J Clin Transl Hepatol; 2023 Apr; 11(2):502-515. PubMed ID: 36643037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lean nonalcoholic fatty liver disease and risk of incident type 2 diabetes mellitus: A literature review and meta-analysis.
    Gao Y; Zhao T; Song S; Duo Y; Gao J; Yuan T; Zhao W
    Diabetes Res Clin Pract; 2023 Jun; 200():110699. PubMed ID: 37169306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Muscle strength, but not body mass index, is associated with mortality in patients with non-alcoholic fatty liver disease.
    Charatcharoenwitthaya P; Karaketklang K; Aekplakorn W
    J Cachexia Sarcopenia Muscle; 2022 Oct; 13(5):2393-2404. PubMed ID: 36017777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonalcoholic Fatty Liver Disease in Lean Subjects: Associations With Metabolic Dysregulation and Cardiovascular Risk-A Single-Center Cross-Sectional Study.
    Semmler G; Wernly S; Bachmayer S; Wernly B; Schwenoha L; Huber-Schönauer U; Stickel F; Niederseer D; Aigner E; Datz C
    Clin Transl Gastroenterol; 2021 Apr; 12(4):e00326. PubMed ID: 33821832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lean NAFLD: An Underrecognized Outlier.
    Wattacheril J; Sanyal AJ
    Curr Hepatol Rep; 2016 Jun; 15(2):134-139. PubMed ID: 27668144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of "indeterminate score" measurements in lean nonalcoholic fatty liver disease patients from western Saudi Arabia.
    Khayyat YM
    World J Hepatol; 2021 Dec; 13(12):2150-2160. PubMed ID: 35070015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of nonalcoholic fatty liver disease on the risk of gallbladder polyps in lean and non-obese individuals: A cohort study.
    Kim NH; Kang JH; Kim HJ
    Hepatobiliary Pancreat Dis Int; 2024 Jan; ():. PubMed ID: 38336522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Weight change and resolution of fatty liver in normal weight individuals with nonalcoholic fatty liver disease.
    Sinn DH; Kang D; Cho SJ; Paik SW; Guallar E; Cho J; Gwak GY
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e529-e534. PubMed ID: 33867441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of characteristics between nonobese and overweight/obese subjects with nonalcoholic fatty liver disease in a South Indian population.
    Vendhan R; Amutha A; Anjana RM; Unnikrishnan R; Deepa M; Mohan V
    Diabetes Technol Ther; 2014 Jan; 16(1):48-55. PubMed ID: 24028151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease.
    Kim Y; Han E; Lee JS; Lee HW; Kim BK; Kim MK; Kim HS; Park JY; Kim DY; Ahn SH; Lee BW; Kang ES; Cha BS; Lee YH; Kim SU
    Gut Liver; 2022 Mar; 16(2):290-299. PubMed ID: 34238770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?
    Younes R; Govaere O; Petta S; Miele L; Tiniakos D; Burt A; David E; Vecchio FM; Maggioni M; Cabibi D; McLeod D; Pareja MJ; Fracanzani AL; Aller R; Rosso C; Ampuero J; Gallego-Durán R; Armandi A; Caviglia GP; Zaki MYW; Liguori A; Francione P; Pennisi G; Grieco A; Birolo G; Fariselli P; Eslam M; Valenti L; George J; Romero-Gómez M; Anstee QM; Bugianesi E
    Gut; 2022 Feb; 71(2):382-390. PubMed ID: 33541866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathological characteristics and metabolic profiles of non-alcoholic fatty liver disease in Indian patients with normal body mass index: Do they differ from obese or overweight non-alcoholic fatty liver disease?
    Kumar R; Rastogi A; Sharma MK; Bhatia V; Garg H; Bihari C; Sarin SK
    Indian J Endocrinol Metab; 2013 Jul; 17(4):665-71. PubMed ID: 23961483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.